SubHero Banner
Text

February 2024

Core topics in this month’s edition include:

  • Simlandi (adalimumab-ryvk) – new biosimilar approval
  • Udenyca Onbody (pegfilgrastim-cbqv) – new biosimilar launch
  • COVID-19 vaccines (Omicron variant XBB.1.5) – vaccine update

Download PDF

Text